The Class II recall covers 3 dosages of clonidine transdermal patches made by Actavis Laboratories, with no adverse health ...

Twelve of the 15 analysts surveyed by S&P Global ( SPGI +1.32%) in April rated the pharmaceutical stock as a "buy" or "strong ...

If you are wondering whether Teva Pharmaceutical Industries at around US$31.22 still offers value or is looking stretched, ...

Following a quiet stretch, the legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva ...

The Federal Circuit reversed a ruling that had wiped out Teva Pharmaceuticals International GmbH’s $177 million Ajovy patent ...

Teva Pharmaceuticals Industries Ltd. dodged some claims and will continue to litigate others in multidistrict litigation brought by drug wholesalers and retailers, as well as a suit brought by a rival ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is featured on the David Einhorn Stock Portfolio: Top 10 Stock Picks. Teva ...

Viatris and Teva Pharmaceutical Industries recently launched separate recalls in the U.S. related to dissolution problems for ...

In its third quarter, Teva booked revenue of $4.48 billion. That was 3% higher year over year, and much of that growth came from leading medications like Austedo, which improved its sales by 38% year ...

Israel’s Teva Pharmaceutical Industries has teamed up with NeuroGen Pharma to jointly promote the wide availability of ...

View post: 'Invincible' Season 4: Who Died in the Show's Bloodiest Battle Yet? Teva’s Zymic Sandals are now on sale for $40, a 50% discount from the original $80 price tag. Available in three ...